SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-017349
Filing Date
2018-01-23
Accepted
2018-01-23 16:03:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d522068d424b5.htm 424B5 289290
2 GRAPHIC g522068g05c73.jpg GRAPHIC 14930
3 GRAPHIC g522068g31r15.jpg GRAPHIC 147120
  Complete submission text file 0001193125-18-017349.txt   513746
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-214411 | Film No.: 18542435
SIC: 2834 Pharmaceutical Preparations